Univariate analysis of factors associated with PFS in patients with POAML
| Factor . | PFS (mo) . | |
|---|---|---|
| Median (95% CI) . | P . | |
| Age (y) | ||
| ≤60 | 198 (109 to not reached) | .006 |
| >60 | 85 (57-161) | |
| Ann Arbor stage | ||
| I | 161 (104 to not reached) | .0001 |
| II to IV | 22 (19-57) | |
| Laterality | ||
| Bilateral | 73 (19-134) | .002 |
| Unilateral | 161 (104 to not reached) | |
| RT dose | ||
| <30.6 Gy | 73 (46-83) | .0001 |
| ≥30.6 Gy | 188 (134 to not reached) | |
| Factor . | PFS (mo) . | |
|---|---|---|
| Median (95% CI) . | P . | |
| Age (y) | ||
| ≤60 | 198 (109 to not reached) | .006 |
| >60 | 85 (57-161) | |
| Ann Arbor stage | ||
| I | 161 (104 to not reached) | .0001 |
| II to IV | 22 (19-57) | |
| Laterality | ||
| Bilateral | 73 (19-134) | .002 |
| Unilateral | 161 (104 to not reached) | |
| RT dose | ||
| <30.6 Gy | 73 (46-83) | .0001 |
| ≥30.6 Gy | 188 (134 to not reached) | |